Emerg Infect Dis. 2023 Aug;29(8):1516-23. doi: 10.3201/eid2908.230007.
Mycolicibacterium neoaurum is a rapidly growing mycobacterium and an emerging cause of human infections. M. neoaurum infections are uncommon but likely underreported, and our understanding of the disease spectrum and optimum management is incomplete. We summarize demographic and clinical characteristics of a case of catheter-related M. neoaurum bacteremia in a child with leukemia and those of 36 previously reported episodes of M. neoaurum infection. Most infections occurred in young to middle-aged adults with serious underlying medical conditions and commonly involved medical devices. Overall, infections were not associated with severe illness or death. In contrast to other mycobacteria species, M. neoaurum was generally susceptible to multiple antimicrobial drugs and responded promptly to treatment, and infections were associated with good outcomes after relatively short therapy duration and device removal. Delays in identification and susceptibility testing were common. We recommend using combination antimicrobial drug therapy and removal of infected devices to eradicate infection.
耻垢分枝杆菌是一种快速生长的分枝杆菌,也是人类感染的一种新兴病因。耻垢分枝杆菌感染并不常见,但可能报告不足,我们对其疾病谱和最佳治疗方法的了解并不完整。我们总结了一例患有白血病的儿童与导管相关的耻垢分枝杆菌菌血症病例以及此前报道的 36 例耻垢分枝杆菌感染病例的人口统计学和临床特征。大多数感染发生在患有严重基础疾病的年轻至中年成年人中,并且常涉及医疗设备。总体而言,感染与严重疾病或死亡无关。与其他分枝杆菌种不同,耻垢分枝杆菌通常对多种抗菌药物敏感,并且对治疗反应迅速,并且在相对较短的治疗时间和去除感染设备后,感染与良好的结局相关。鉴定和药敏试验的延迟很常见。我们建议使用联合抗菌药物治疗和去除感染的设备来根除感染。